在iPSC衍生的心肌细胞:当前的局限性和治疗前景中的心律失常风险
Dhienda C Shahannaz1,2, Tadahisa Sugiura2, Brandon E Ferrell2
1Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia.
Medicina (Kaunas, Lithuania)
|November 27, 2025
概括
诱导多能干细胞衍生的心肌细胞 (iPSC-CMs) 对研究心律失常有前途,但存在风险. 研究正在探索新的治疗方法,以提高iPSC-CM在临床使用中的安全性.
科学领域:
- 心脏病学 心脏病学
- 干细胞生物学 干细胞生物学
- 电子生理学 电子生理学
背景情况:
- 诱导多能干细胞衍生心肌细胞 (iPSC-CMs) 为心律失常研究提供了针对患者的特定模型.
- 对iPSC-CMs的临床转化受到来自移植细胞的节律失常风险的限制.
研究的目的:
- 在心律失常模型中审查iPSC-CMs的局限性.
- 探索治疗策略,以减轻iPSC-CMs的节律失常风险.
主要方法:
- 对过去二十年研究的综合文献综述.
- 专注于iPSC-CM电生理学,节律失调的潜力和干预措施.
- 包括同行评审期刊,临床试验报告和干细胞技术进步.
主要成果:
- iPSC-CMs存在挑战,包括细胞异质性,不成熟性和前节律潜力.
- 成熟协议,共同培养系统和基因编辑方面的进步显示出增强iPSC-CM安全性的前景.
- 目前的模型需要进一步开发以获得可靠的临床应用.
结论:
- 减轻iPSC-CM节律失常的风险需要改进差异化和成熟协议.
- 多方面的治疗干预对于安全的临床转换至关重要.
- 持续的研究对于克服安全障碍和实现iPSC-CMs在心脏医学中的潜力至关重要.
关键词:
发生心律失常的风险心脏节律失常的心脏节律失常.心脏成熟协议的心脏成熟协议在心肌细胞中共同培养系统.电生理学建模 电生理学建模在心脏病学中基因编辑.由iPSC衍生的心肌细胞.在心律失常中进行药理干预.潜在的前节律失常潜力干细胞疗法是一种干细胞疗法.更多相关视频
10:30Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
3.4K
08:39Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: December 22, 2020
4.6K
相关概念视频
EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
